Polypharmacy and Dynapenia in Older Adults Undergoing Rehabilitation After Fracture or Elective Orthopedic Surgery
Authors:
Open Access
Abstract
Background and Objectives: Polypharmacy is common among older adults and its impact on the onset of dynapenia, reduced muscle strength and function, is largely unknown. Older adults hospitalized for either post-fracture or elective orthopedic surgery (knee, femur, or hip) and undergoing rehabilitation were included to investigate the association between polypharmacy and dynapenia. A further aim is to investigate associations between polypharmacy and dynapenia with outcomes including mortality, falls, and hospitalizations. Materials and Methods: On the fifth day following surgery, medical doctors administered a structured questionnaire along with physical and instrumental assessments. Polypharmacy was defined as the concurrent and regular use of 5 or more medications, dynapenia was assessed by measuring handgrip strength. The association between dynapenia and polypharmacy was detected with logistic regression, and their impact on adverse outcomes was assessed using Cox models, Kaplan–Meier curves and log-rank tests. Results: A total of 205 older adults (mean age 77.5 years; 79.5% women) were enrolled. After adjusting for sex, age, and the presence of multidimensional frailty, dynapenia was significantly associated with increased adverse outcomes such as mortality, falls, and hospitalizations (HR 2.96, 95% CI 1.22–7.20, p = 0.016). Similarly, polypharmacy was independently linked to a higher risk of mortality, falls and hospitalizations (HR 2.23, 95% CI 1.24–4.10, p = 0.007). At 6 months follow-up, polypharmacy showed a strong and significant association with dynapenia (adjusted OR 2.63, 95% CI 1.21–4.63, p = 0.019). Conclusions: These findings suggest that polypharmacy is strongly associated with dynapenia, both conditions are associated with adverse clinical outcomes in older hospitalized patients. Close monitoring and tailored interventions are recommended to mitigate these risks and improve rehabilitation outcomes in this vulnerable population.Keywords
This publication has 41 references indexed in Scilit:
- Dynapenia-abdominal obesity and mortality risk, is independent effect obscured by age and frailty?:Birjand Longitudinal Aging Study (BLAS)Journal of Diabetes & Metabolic Disorders, 2024
- Global and regional prevalence of polypharmacy and related factors, 1997–2022: An umbrella reviewArchives of Gerontology and Geriatrics, 2024
- Malnutrition and Polypharmacy in Older Adult Patients Receiving Home Care Nursing Services: A Cross-sectional StudyJournal of the American Medical Directors Association, 2023
- Dynapenic abdominal obesity and incident multimorbidity: findings from the English longitudinal study on ageingAging Clinical and Experimental Research, 2023
- Sarcopenia is associated with a greater risk of polypharmacy and number of medications: a systematic review and meta‐analysisJournal of Cachexia, Sarcopenia and Muscle, 2023
- Associations between dynapenia, cardiovascular hospitalizations, and all‐cause mortality among patients on haemodialysisJournal of Cachexia, Sarcopenia and Muscle, 2022
- Prevalence of dynapenia and presarcopenia related to aging in adult community-dwelling Mexicans using two different cut-off pointsEuropean Geriatric Medicine, 2018
- Polypharmacy Is Associated With Higher Frailty Risk in Older People: An 8-Year Longitudinal Cohort StudyJournal of the American Medical Directors Association, 2017
- Psychotropic drugs and the risk of fall injuries, hospitalisations and mortality among older adultsInternational Journal of Geriatric Psychiatry, 2016
- Validation of the Mini Nutritional Assessment short-form (MNA®-SF): A practical tool for identification of nutritional statusThe Journal of nutrition, health and aging, 2009